Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
O
O’Keefe, Kylie
PTC Therapeutics, Inc.
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Kylie O’Keefe
Favorite
Ocejo Gallegos, Jesús Antonio
University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Jesús Antonio Ocejo Gallegos
Favorite
O'Day, Steven
Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Steven O'Day
Favorite
O'Donohue, Tara
Memorial Sloan Kettering Cancer Center
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Tara O'Donohue
Favorite
Oike, Naoki
Niigata University
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Naoki Oike
Favorite
Okuno, Scott
Mayo Clinic
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Scott Okuno
Favorite
Olofsson Bagge, Roger
Sahlgrenska University Hospital
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Roger Olofsson Bagge
Favorite
Olshinka, Noam
Hadassah university medical center
Paper 05 - MUSCULOSKELETAL ONCOLOGY: PATIENT TRIAGE AND MANAGEMENT DURING THE COVID-19 PANDEMIC
Noam Olshinka
Favorite
Olson, Adam
Department of Radiation Oncology, University of Pittsburgh
Paper 93 - TGF-B INHIBITION DURING RADIATION RESULTS IN IMMUNE MICROENVIRONMENT REMODELING IN A HUMANIZED MOUSE MODEL OF EWING SARCOMA
Adam Olson
Favorite
Olszanski, Anthony
Johns Hopkins Sidney Kimmel Cancer Center
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Anthony Olszanski
Favorite
Ong, Choon Kiat
National Cancer Centre Singapore
Paper 15 - SPATIAL TRANSCRIPTOMICS REVEAL TOPOLOGICAL IMMUNE LANDSCAPES OF ASIAN HEAD AND NECK ANGIOSARCOMA
Choon Kiat Ong
Favorite
Orbach, Daniel
SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Institut Curie and Paris Sciences et Lettres
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Daniel Orbach
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Daniel Orbach
Favorite
Ording Müller, LS
Department of Radiology and Intervention Unit for Paediatric Radiology, Oslo University Hospital
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
LS Ording Müller
Favorite
O'Regan, Luke
Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Luke O'Regan
Favorite
Oristian, Kristianne
Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Kristianne Oristian
Favorite
Paper 30 - SUCCESS AND CHALLENGES OF GENERATING A GENETICALLY ENGINEERED MOUSE MODEL OF CIC-DUX4 SARCOMA
Kristianne Oristian
Favorite
Ortuzar Feliu, Waldo
Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Waldo Ortuzar Feliu
Favorite
Osborne, Stuart
F. Hoffmann-La Roche Ltd
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Stuart Osborne
Favorite
Ostwal, Vikas
Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Vikas Ostwal
Favorite
O'Sullivan, Maureen
Children's Health Ireland at Crumlin & Trinity College Dublin
Mentorship Session 8: How to Get Involved in CTOS
Maureen O'Sullivan
Favorite
Ovrebo, Kjell
TARPSWG
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Kjell Ovrebo
Favorite
Oza, Jay
Dana Farber Cancer Institute
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Jay Oza
Favorite
Ozenberger, Benjamin
Huntsman Cancer Institute
Paper 16 - EWSR1:ATF1 BINDS PROMOTER AND ENHANCER REGIONS TO REPROGRAM TRANSCRIPTION IN CLEAR CELL SARCOMA
Benjamin Ozenberger
Favorite
Back to Top